Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology

Cancer

Volumn 114, Issue 4, 2008, Pages 236-241

  Che, Longwen ^a   Yang, Bin ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atypcial glandular cells; Atypical endocervical cells; Atypical glandular ceils; Cervical cytology; Colposcopy; Papanicolaou test; Reflex HPV DNA

Indexed keywords

VIRUS DNA;

ARTICLE; COLPOSCOPY; CURETTAGE; DNA DETERMINATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFLEX HUMAN PAPILLOMAVIRUS TESTING; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DIAGNOSIS; ADULT; AGED; FOLLOW UP; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 51649124327     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23639     Document Type: Article

References (20)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. 1999. CA Cancer J Clin. 1999;48:8-31.
2. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57:105-111.
3. Koss L. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA. 1989;261:737-743.
4. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101.
5. Wright TC. HPV DNA testing for cervical cancer screening. Int J Gynaecol Obstet. 2006;95(suppl 1):S239-S246.
6. American College of Obstetricians and Gynecologists.ACOG Practice Bulletin.Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus. Obstet Gynecol. 2005;105:905-918.
7. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355.
8. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
9. Schnatz PF, Guile M, O'Sullivan D, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006;107:701-708.
10. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol. 2005;105:494-500.
11. DeSimone CP, Day ME, Tovar MM, et al. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006;107:1285-1291.
12. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol. 2006;104:366-371.
13. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol. 1999;30:816-825.
14. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol. 2004;121:87-92.
15. Oliveira E, Derchain S, Rabelo-Santos SH, et al. Detection of high-risk human papillomavirus DNA by hybrid capture II in women referred due to atypical glandular cells in the primary screening. Diagn Cytopathol. 2004;31:19-21.
16. Lee KR, Daragh TM, Joste NE, et al. Atypical glandular cells of undetermined significance (AGUS). Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol. 2002,117:96-102.
17. Raab SS, Geisinger KR, Silverman JF, Thomas PA, Stanley MW. Interobserver variability of Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance. Am JClin Pathol. 1998;110:653-659.
18. Saqi A, Gupta PK, Erroll M, et al. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells. Diagn Cytopathol. 2006;34:235-239.
19. Chhieng CC, Elgert P, Cohen JM, Cangiarella J. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer (Cancer Cytopathol). 2001;93:1-7.
20. Simsir A, Hwang S, Cangiarella J, et al. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of the cell of origin. Cancer (Cancer Cytopathol). 2003;99:323-330.